North China Pharmaceutical Co Ltd
SSE:600812
Wall Street
Price Targets
Price Targets Summary
North China Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for North China Pharmaceutical Co Ltd is 12.39 CNY .
Price Targets
Net Income
Forecast
Net Income Estimate
North China Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for North China Pharmaceutical Co Ltd's net income is -27%. The projected CAGR for the next 3 years is 233%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is North China Pharmaceutical Co Ltd's stock price target?
Price Target
12.39
CNY
According to Wall Street analysts, the average 1-year price target for North China Pharmaceutical Co Ltd is 12.39 CNY .
What is North China Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
8%
For the last 8 years the compound annual growth rate for North China Pharmaceutical Co Ltd's revenue is 3%. The projected CAGR for the next 3 years is 8%.
What is North China Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
233%
For the last 8 years the compound annual growth rate for North China Pharmaceutical Co Ltd's net income is -27%. The projected CAGR for the next 3 years is 233%.
You don't have any saved screeners yet
